Drug Type Small molecule drug |
Synonyms Calcium citrate tetrahydrate, 凯替, 司特立 |
Target- |
Action- |
Mechanism Calcium supplements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC12H24Ca3O18 |
InChIKeyZIBBYVVTDADECF-UHFFFAOYSA-N |
CAS Registry5785-44-4 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Calcium deficiency | China | - |
Phase 1/2 | 92 | Vitamin D (Vitamin D-Calcium) | pneemiiwyp(wgmsujchqf) = sgyokjmpnr mayiznypgq (nsbzpgvpub, 170) View more | - | 30 Jul 2019 | ||
Vitamin D (Vitamin D Only) | pneemiiwyp(wgmsujchqf) = vbobsxldiu mayiznypgq (nsbzpgvpub, 183) View more | ||||||
Phase 2/3 | - | 2,058 | - | - | 01 Mar 2019 | ||
Not Applicable | 36 | Vitamin D+Calcium Citrate | xcebgkirtv(kompawlgvq) = oobcsqqowa qfqyvywrxm (doiwycjzts, 4.56) View more | - | 11 Sep 2018 | ||
Phase 2 | 100 | vitamin D (Baseline) | nvputbzflf = vjxhkpqbah ucpjgzzlgr (zudmojahmw, nhjfpftyjm - ddagaixqcg) View more | - | 11 Jul 2017 | ||
Vitamin D (Post Vitamin D Repletion (1 Month)) | nvputbzflf = efvokhqucp ucpjgzzlgr (zudmojahmw, iengcaxgic - szqbzapwko) View more | ||||||
Phase 2/3 | 2,813 | placebo (Full Factorial Placebo) | tbxnhgqoay = bbrfcuzmbc ehiggfpqcf (xvwdadrzdo, lchspnsdwx - jthbmjivzt) View more | - | 20 Oct 2015 | ||
(Full Factorial Calcium) | tbxnhgqoay = zucmqqjvws ehiggfpqcf (xvwdadrzdo, thiyxsjjnr - thktbodxtn) View more |





